Raub Brock Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
63,763
-15,698
-20% -$3.38M 4.42% 4
2026
Q1
$17.3M Sell
79,461
-9,805
-11% -$2.17M 4.38% 4
2025
Q4
$20.4M Sell
89,266
-3,319
-4% -$756K 4.54% 5
2025
Q3
$21.4M Sell
92,585
-1,767
-2% -$360K 4.61% 5
2025
Q2
$17.5M Sell
94,352
-3,127
-3% -$581K 3.82% 10
2025
Q1
$20.4M Sell
97,479
-5,798
-6% -$1.13M 4.56% 3
2024
Q4
$18.4M Buy
103,277
+854
+0.8% +$157K 3.9% 13
2024
Q3
$20.2M Sell
102,423
-2,306
-2% -$430K 4.11% 10
2024
Q2
$18M Sell
104,729
-1,555
-1% -$258K 3.92% 8
2024
Q1
$19.4M Sell
106,284
-6,624
-6% -$1.14M 4.1% 9
2023
Q4
$17.5M Sell
112,908
-25,870
-19% -$3.77M 3.67% 16
2023
Q3
$20.7M Sell
138,778
-4,092
-3% -$601K 4.11% 12
2023
Q2
$19.2M Sell
142,870
-1,764
-1% -$259K 3.61% 20
2023
Q1
$23.1M Buy
144,634
+2,928
+2% +$448K 4.43% 4
2022
Q4
$22.9M Sell
141,706
-17,979
-11% -$2.76M 4.68% 3
2022
Q3
$21.4M Sell
159,685
-21,442
-12% -$3.08M 4.47% 7
2022
Q2
$27.7M Sell
181,127
-26,888
-13% -$4.11M 5.3% 2
2022
Q1
$33.7M Sell
208,015
-39,654
-16% -$5.76M 5.74% 1
2021
Q4
$26.7M Hold
247,669
4.06% 14
2021
Q3
$26.7M Sell
247,669
-2,637
-1% -$301K 4.06% 14
2021
Q2
$28.2M Sell
250,306
-6,082
-2% -$685K 4.86% 11
2021
Q1
$27.7M Sell
256,388
-6,850
-3% -$733K 4.38% 9
2020
Q4
$28.2M Sell
263,238
-5,940
-2% -$571K 4.57% 5
2020
Q3
$23.6M Sell
269,178
-1,673
-0.6% -$158K 4% 14
2020
Q2
$26.6M Sell
270,851
-16,057
-6% -$1.41M 4.94% 1
2020
Q1
$21.9M Sell
286,908
-9,262
-3% -$789K 4.77% 2
2019
Q4
$26.2M Buy
+296,170
New +$24.6M 4.6% 7

Other funds holding ABBV